Levaquin Lawsuit News: FDA Advisors Recommend Stronger Safety Warnings for Fluoroquinolone Antibiotics, Bernstein Liebhard LLP Reports

November 16, 2015 - As Levaquin lawsuits (http://www.levaquinlawsuitcenter.com/) and other product liability claims involving fluoroquinolone antibiotics continue to mount in U.S. courts, Bernstein Liebhard LLP notes that two advisory committees to the U.S. Food & Drug Administration (FDA) have overwhelmingly voted to recommend stronger safety warnings for this class of medications. The agency convened a meeting of its Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on November 6th to discuss the safety of fluoroquinolone antibiotics in the treatment of sinus infections, urinary-tract infections and bronchitis that worsens existing chronic obstructive pulmonary disease. The committees ultimately voted 21-0 to recommend stronger warnings for sinusitis; 18-2, with one abstention, on bronchitis; and 20-1 regarding urinary-tract infections. While the FDA is not required to adopt the recommendations of its advisory panels, it usually does so.

"Our Firm is currently investigating product liability claims involving fluoroquinolones like Levaquin and the onset of peripheral neuropathy, a painful and potentially debilitating nerve condition. We look forward to the FDA's final decision regarding the advisory committees' recommendations," says Sandy A. Liebhard LLP, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free, no-obligation Levaquin lawsuit reviews to patients who may have been harmed by one of these antibiotics.

Fluoroquinolone Side Effects
Fluoroquinolone antibiotics include medications sold under the brand names Levaquin, Cipro and Avelox. It is estimated that some 36 million fluoroquinolone prescriptions were written in 2012, placing these antibiotics among the most commonly prescribed medications. However, the FDA has become increasingly concerned about their potentially devastating side effects, including peripheral neuropathy, cardiac rhythm disturbances, tendon injuries, and cognitive problems.

Court documents indicate that nearly 200 Levaquin peripheral neuropathy lawsuits and other fluoroquinolone cases involving the drugs' alleged association with this debilitating nerve condition are pending in a federal litigation now underway in the U.S. District Court, District of Minnesota. Among other things, plaintiffs claim that the manufacturers of Levaquin, Avelox and Cipro failed to provide doctors and patients with adequate warnings regarding this possible complication. The lawsuits also note that while information about peripheral neuropathy was first included on the drugs' labels in 2004, the FDA mandated further revisions in 2013 in order to better reflect the rapid onset of the condition and the potential for permanent nerve damage. (In Re: Fluoroquinolone Products Liability Litigation – MDL No. 2642)

Individuals who were diagnosed with permanent peripheral neuropathy allegedly due to their use of a fluoroquinolone antibiotic may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Levaquin, Cipro or Avelox lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can also be obtained by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.levaquinlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author